3-124326012-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_001388419.1(KALRN):c.1125C>T(p.Ser375Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00798 in 1,612,926 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0077 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0080 ( 55 hom. )
Consequence
KALRN
NM_001388419.1 synonymous
NM_001388419.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.16
Publications
3 publications found
Genes affected
KALRN (HGNC:4814): (kalirin RhoGEF kinase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.153).
BP6
Variant 3-124326012-C-T is Benign according to our data. Variant chr3-124326012-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2654085.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-5.16 with no splicing effect.
BS2
High AC in GnomAd4 at 1179 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KALRN | NM_001388419.1 | c.1125C>T | p.Ser375Ser | synonymous_variant | Exon 7 of 60 | ENST00000682506.1 | NP_001375348.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KALRN | ENST00000682506.1 | c.1125C>T | p.Ser375Ser | synonymous_variant | Exon 7 of 60 | NM_001388419.1 | ENSP00000508359.1 |
Frequencies
GnomAD3 genomes AF: 0.00774 AC: 1177AN: 152134Hom.: 11 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1177
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00691 AC: 1721AN: 249216 AF XY: 0.00686 show subpopulations
GnomAD2 exomes
AF:
AC:
1721
AN:
249216
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00801 AC: 11694AN: 1460674Hom.: 55 Cov.: 30 AF XY: 0.00785 AC XY: 5706AN XY: 726574 show subpopulations
GnomAD4 exome
AF:
AC:
11694
AN:
1460674
Hom.:
Cov.:
30
AF XY:
AC XY:
5706
AN XY:
726574
show subpopulations
African (AFR)
AF:
AC:
241
AN:
33472
American (AMR)
AF:
AC:
184
AN:
44622
Ashkenazi Jewish (ASJ)
AF:
AC:
550
AN:
26124
East Asian (EAS)
AF:
AC:
433
AN:
39696
South Asian (SAS)
AF:
AC:
167
AN:
85922
European-Finnish (FIN)
AF:
AC:
118
AN:
53278
Middle Eastern (MID)
AF:
AC:
68
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
9387
AN:
1111450
Other (OTH)
AF:
AC:
546
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
593
1186
1778
2371
2964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00774 AC: 1179AN: 152252Hom.: 11 Cov.: 32 AF XY: 0.00689 AC XY: 513AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
1179
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
513
AN XY:
74438
show subpopulations
African (AFR)
AF:
AC:
292
AN:
41550
American (AMR)
AF:
AC:
105
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
67
AN:
3472
East Asian (EAS)
AF:
AC:
44
AN:
5170
South Asian (SAS)
AF:
AC:
11
AN:
4818
European-Finnish (FIN)
AF:
AC:
11
AN:
10608
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
619
AN:
68014
Other (OTH)
AF:
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
51
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
KALRN: BP4, BP7, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.